dod dsip Capturing Non-Dilutive Funding from Department of Defense: SBIR Program Overview (Part II of III) Biz Opps: DoD SBIR 22.4

Researchers can adjust dosing and duration based on the desired therapeutic effects, target area, severity of condition, and other factors

investigated the delivery of IGF1 to CNS, confirming they reached CNS target sites of rats by administering a mixture of [ 125 I]-labeled IGF1

Some researchers prefer to add more water (3-5 mL) to create a more dilute solution that requires a larger, easier-to-measure draw

Fatigue or mild digestive changes may occur in some users, making monitoring by a healthcare provider advisable

Note the date of reconstitution, amount of water added, resulting concentration, and calculated draw volume for your target dose